Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 271 - Recent Statistical Advances of Handling Nonproportional Hazards in Study Design and Data Interpretation
Type: Topic Contributed
Date/Time: Tuesday, August 9, 2022 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #323162
Title: Hypothesis Testing Under Non-Proportion Hazards: Methodologic Challenges and Interpretations
Author(s): Jianghua He* and Huan Cheng
Companies: University of Kansas Medical Center and University of Kansas Medical Center
Keywords: Survival Analysis; Cox Models; Clinical Trails; Censoring
Abstract:

The commonly used proportional hazards model and log-rank test for survival outcomes are built upon and most powerful under the proportional hazards (PH) assumption that is often violated in oncology trials. Various research methods have been proposed to deal with Non PH (NPH) situations, such as modeling time-varying effects, estimating average effects, and various weighted log-rank/combo tests. There are some methodologic and clinical challenges in applying these methods. For example, independent censoring becomes an issue that affect testing and estimates and the estimates losses its original interpretations; weighted log-rank tests weight the effect differently at different time points without adequate justifications; different weighted log-rank tests may get opposite conclusions etc. In this presentation, simulation studies are done to show the impact of independent censoring on data analysis using Cox model or (weighted) log-rank/combo tests and explore the interpretations of the underlying hypotheses and testing results. Potential remedial methods are also presented, and their performances are examined.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program